Mice transgenic for monocyte-tropic HIV type 1 produce infectious virus and display plasma viremia: A new in vivo system for studying the postintegration phase of HIV replication

Jessie Browning Paul, Emilie Jeanne Wang, Massimo Pettoello-Mantovani, Christina Raker, Sergey Yurasov, Marsha M. Goldstein, James W. Horner, John Chan, Harris Goldstein

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

To generate an in vivo system for investigating the postintegration phase of HIV-1 replication, mouse lines transgenic for a full-length infectious proviral clone of a monocyte-tropic HIV-1 isolate, HIV-1(JR-SCF), were constructed. Leukocytes from two independent JR-CSF transgenic mouse lines produced HIV-1 that infected human PBMCs. Plasma viremia was detected in these mice at levels (mean, >60,000 HIV RNA copies/ml) comparable to those reported for HIV-1-infected individuals. The levels of HIV RNA in these mice increased several-fold after either treatment with the superantigen Staphylococcus enterotoxin B or infection with Mycobacterium tuberculosis. Thus, a provirus encoding a monocyte-tropic HIV-1 strain under the control of its LTR expressed as a transgene in mice can proceed through the postintegration replication phase and produce infectious virus. In addition, the presence of plasma viremia that can be monitored by measuring plasma HIV- 1 RNA levels permits these mice to be used to study the impact of different interventions on modulating in vivo HIV-1 production. Therefore, these mice provide a novel manipulable system to investigate the in vivo regulation of HIV-1 production by factors that activate the immune system. Furthermore, this murine system should be useful in delineating the role of human-specific factors in modulating HIV-1 replication and investigating the in vivo therapeutic efficacy of agents that target the postintegration stages of HIV- 1 replication.

Original languageEnglish (US)
Pages (from-to)481-492
Number of pages12
JournalAIDS Research and Human Retroviruses
Volume16
Issue number5
DOIs
StatePublished - Mar 20 2000

Fingerprint

Viremia
Transgenic Mice
HIV-1
Monocytes
HIV
Viruses
RNA
Proviruses
Superantigens
Transgenes
Mycobacterium tuberculosis
Immune System
Leukocytes
Clone Cells

ASJC Scopus subject areas

  • Immunology
  • Virology

Cite this

Mice transgenic for monocyte-tropic HIV type 1 produce infectious virus and display plasma viremia : A new in vivo system for studying the postintegration phase of HIV replication. / Paul, Jessie Browning; Wang, Emilie Jeanne; Pettoello-Mantovani, Massimo; Raker, Christina; Yurasov, Sergey; Goldstein, Marsha M.; Horner, James W.; Chan, John; Goldstein, Harris.

In: AIDS Research and Human Retroviruses, Vol. 16, No. 5, 20.03.2000, p. 481-492.

Research output: Contribution to journalArticle

Paul, Jessie Browning ; Wang, Emilie Jeanne ; Pettoello-Mantovani, Massimo ; Raker, Christina ; Yurasov, Sergey ; Goldstein, Marsha M. ; Horner, James W. ; Chan, John ; Goldstein, Harris. / Mice transgenic for monocyte-tropic HIV type 1 produce infectious virus and display plasma viremia : A new in vivo system for studying the postintegration phase of HIV replication. In: AIDS Research and Human Retroviruses. 2000 ; Vol. 16, No. 5. pp. 481-492.
@article{4ab9e1fd2f0642b98a49fc9f0503a078,
title = "Mice transgenic for monocyte-tropic HIV type 1 produce infectious virus and display plasma viremia: A new in vivo system for studying the postintegration phase of HIV replication",
abstract = "To generate an in vivo system for investigating the postintegration phase of HIV-1 replication, mouse lines transgenic for a full-length infectious proviral clone of a monocyte-tropic HIV-1 isolate, HIV-1(JR-SCF), were constructed. Leukocytes from two independent JR-CSF transgenic mouse lines produced HIV-1 that infected human PBMCs. Plasma viremia was detected in these mice at levels (mean, >60,000 HIV RNA copies/ml) comparable to those reported for HIV-1-infected individuals. The levels of HIV RNA in these mice increased several-fold after either treatment with the superantigen Staphylococcus enterotoxin B or infection with Mycobacterium tuberculosis. Thus, a provirus encoding a monocyte-tropic HIV-1 strain under the control of its LTR expressed as a transgene in mice can proceed through the postintegration replication phase and produce infectious virus. In addition, the presence of plasma viremia that can be monitored by measuring plasma HIV- 1 RNA levels permits these mice to be used to study the impact of different interventions on modulating in vivo HIV-1 production. Therefore, these mice provide a novel manipulable system to investigate the in vivo regulation of HIV-1 production by factors that activate the immune system. Furthermore, this murine system should be useful in delineating the role of human-specific factors in modulating HIV-1 replication and investigating the in vivo therapeutic efficacy of agents that target the postintegration stages of HIV- 1 replication.",
author = "Paul, {Jessie Browning} and Wang, {Emilie Jeanne} and Massimo Pettoello-Mantovani and Christina Raker and Sergey Yurasov and Goldstein, {Marsha M.} and Horner, {James W.} and John Chan and Harris Goldstein",
year = "2000",
month = "3",
day = "20",
doi = "10.1089/088922200309142",
language = "English (US)",
volume = "16",
pages = "481--492",
journal = "AIDS Research and Human Retroviruses",
issn = "0889-2229",
publisher = "Mary Ann Liebert Inc.",
number = "5",

}

TY - JOUR

T1 - Mice transgenic for monocyte-tropic HIV type 1 produce infectious virus and display plasma viremia

T2 - A new in vivo system for studying the postintegration phase of HIV replication

AU - Paul, Jessie Browning

AU - Wang, Emilie Jeanne

AU - Pettoello-Mantovani, Massimo

AU - Raker, Christina

AU - Yurasov, Sergey

AU - Goldstein, Marsha M.

AU - Horner, James W.

AU - Chan, John

AU - Goldstein, Harris

PY - 2000/3/20

Y1 - 2000/3/20

N2 - To generate an in vivo system for investigating the postintegration phase of HIV-1 replication, mouse lines transgenic for a full-length infectious proviral clone of a monocyte-tropic HIV-1 isolate, HIV-1(JR-SCF), were constructed. Leukocytes from two independent JR-CSF transgenic mouse lines produced HIV-1 that infected human PBMCs. Plasma viremia was detected in these mice at levels (mean, >60,000 HIV RNA copies/ml) comparable to those reported for HIV-1-infected individuals. The levels of HIV RNA in these mice increased several-fold after either treatment with the superantigen Staphylococcus enterotoxin B or infection with Mycobacterium tuberculosis. Thus, a provirus encoding a monocyte-tropic HIV-1 strain under the control of its LTR expressed as a transgene in mice can proceed through the postintegration replication phase and produce infectious virus. In addition, the presence of plasma viremia that can be monitored by measuring plasma HIV- 1 RNA levels permits these mice to be used to study the impact of different interventions on modulating in vivo HIV-1 production. Therefore, these mice provide a novel manipulable system to investigate the in vivo regulation of HIV-1 production by factors that activate the immune system. Furthermore, this murine system should be useful in delineating the role of human-specific factors in modulating HIV-1 replication and investigating the in vivo therapeutic efficacy of agents that target the postintegration stages of HIV- 1 replication.

AB - To generate an in vivo system for investigating the postintegration phase of HIV-1 replication, mouse lines transgenic for a full-length infectious proviral clone of a monocyte-tropic HIV-1 isolate, HIV-1(JR-SCF), were constructed. Leukocytes from two independent JR-CSF transgenic mouse lines produced HIV-1 that infected human PBMCs. Plasma viremia was detected in these mice at levels (mean, >60,000 HIV RNA copies/ml) comparable to those reported for HIV-1-infected individuals. The levels of HIV RNA in these mice increased several-fold after either treatment with the superantigen Staphylococcus enterotoxin B or infection with Mycobacterium tuberculosis. Thus, a provirus encoding a monocyte-tropic HIV-1 strain under the control of its LTR expressed as a transgene in mice can proceed through the postintegration replication phase and produce infectious virus. In addition, the presence of plasma viremia that can be monitored by measuring plasma HIV- 1 RNA levels permits these mice to be used to study the impact of different interventions on modulating in vivo HIV-1 production. Therefore, these mice provide a novel manipulable system to investigate the in vivo regulation of HIV-1 production by factors that activate the immune system. Furthermore, this murine system should be useful in delineating the role of human-specific factors in modulating HIV-1 replication and investigating the in vivo therapeutic efficacy of agents that target the postintegration stages of HIV- 1 replication.

UR - http://www.scopus.com/inward/record.url?scp=0034689322&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034689322&partnerID=8YFLogxK

U2 - 10.1089/088922200309142

DO - 10.1089/088922200309142

M3 - Article

C2 - 10772534

AN - SCOPUS:0034689322

VL - 16

SP - 481

EP - 492

JO - AIDS Research and Human Retroviruses

JF - AIDS Research and Human Retroviruses

SN - 0889-2229

IS - 5

ER -